(S)-Lactate
Grundinformationen
- CAS
72-08-2- Standard-SMILES
C[C@H](O)C(=O)[O-]- InChIKey
JVTAAEKCZFNVCJ-REOHCLBHSA-M- Summenformel
- C3H5O3-
- Durchschnittliche Molmasse
- 89,07 g/mol
- Monoisotopische Masse
- 89,0244176
Überblick
(S)-lactate is an optically active form of lactate having (S)-configuration. It has a role as a Saccharomyces cerevisiae metabolite. It is a conjugate base of a (S)-lactic acid. It is an enantiomer of a (R)-lactate.
Namen und Bezeichner
- Bevorzugter Name
- (S)-Lactate
- IUPAC
- (2S)-2-hydroxypropanoate
- Englischer Name
- L-Lactic acid, 40% soln
- Summenformel
- C3H5O3
- Molmasse
- 89.07
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
72-08-2- PubChem CID
- 5460161
- DTXSID
DTXSID801018949- ChEMBL
CHEMBL507018- ChEBI
CHEBI:16651- UNII
- 435SSH7H89
- Nikkaji
- J555.329F
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 0,2
- Polarare Oberfläche (TPSA)
- 60,4 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 0
- Schwere Atome
- 6
- Formalladung
- -1
- Komplexität
- 53,5
Physikochemische Eigenschaften
- Siedepunkt
- 227.561 · 227.561±0.00 °C(Press: 760.00 Torr)(predicted)
- pka
- 3.906 · 3.906±0.11(predicted)
Sicherheit und Regulatorisches
Toxikologische Informationen
Health Effects
Chronically high levels of Lactic acid are associated with at least a dozen inborn errors of metabolism including: 2-Methyl-3-hydroxybutyryl CoA dehydrogenase deficiency, Biotinidase deficiency, Fructose-1,6-diphosphatase deficiency, Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease, Glycogenosis, Type IB, Glycogenosis, Type IC, Glycogenosis, Type VI. Hers disease, Lactic Acidemia, Leigh Syndrome, Methylmalonate Semialdehyde Dehydrogenase Deficiency, Pyruvate Decarboxylase E1 Component Deficiency, Pyruvate dehydrogenase complex deficiency, Pyruvate dehydrogenase deficiency, Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency).
Toxicity Summary
Accumulation of L-lactic acid in the body has been shown to be toxic. At times of lactic acidosis, when excess intracellular lactate is released into the blood, maintenance of electroneutrality of the blood requires that a cation be released into the blood, as well. This can reduce blood pH. Lactate may exert a strong action over GABAergic networks in the developing brain, making them more inhibitory than it was previously assumed, acting either through better support of metabolites, or alterations in base intracellular pH levels, or both. (Wikipedia)
Carcinogen Classification
Not listed by IARC.
No indication of carcinogenicity to humans (not listed by IARC).
Chemie und Industrie
Verwendung und Herstellung
Anbieter1 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…